Can CVS Health Maintain Its Growth Through the End of 2025?

After struggling for a few years, CVS Health (NYSE: CVS) is finally rebounding. Its shares have soared this year by 77%, largely due to improved financial results.That said, the pharmacy giant still has a lot to do as it tries to fix parts of its business that still aren't performing as well as it would like. If CVS can make progress along those lines, it could maintain its recent momentum through the end of the year and perhaps carry it into 2026.Should investors consider investing in CVS Health as the year draws to a close?Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool